http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108033949-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108033949-B |
titleOfInvention | 6-(2-Dipropylaminoacetamido)quinazoline compounds and their preparation and application |
abstract | The invention discloses a 6-(2-dipropylaminoacetamido)quinazoline compound and its preparation and application. The 6-(2-dipropylaminoacetamido) quinazoline compounds provided by the present invention are effective against human breast cancer cell line MCF-7, human lung cancer cell line A-549, human promyelocytic leukemia cell line HL-60, human Cervical cancer cell line Siha has significant inhibitory activity and is expected to be used in the preparation of drugs for preventing or treating human breast cancer, human lung cancer, human leukemia and human cervical cancer. The invention provides a preparation method of the 6-(2-dipropylaminoacetamido)quinazoline compound. The preparation method is simple, easy to operate, readily available raw materials, low in production cost, and suitable for practical use. |
priorityDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.